InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Wednesday, 11/16/2016 5:26:00 PM

Wednesday, November 16, 2016 5:26:00 PM

Post# of 4860
GILD’s Momelotinib goes 1-for-2 in SIMPLIFY/1-2 trials: #msg-126609986.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News